Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 Help Chronic Pain Research: Comparison Table

Rat Achilles tendon injury 52% greater tensile strength at 14 days, improved collagen alignment, reduced IL-6/TNF-alpha No human trials. Dosing, safety, efficacy unvalidated Promising preclinical data with zero clinical confirmation Rodent gastric ulcer healin

This comparison does not assign a generated winner or score.

  • Rat Achilles tendon injury
  • 52% greater tensile strength at 14 days, improved collagen alignment, reduced IL-6/TNF-alpha
  • No human trials. Dosing, safety, efficacy unvalidated
  • Promising preclinical data with zero clinical confirmation
  • Rodent gastric ulcer healing
  • Accelerated mucosal regeneration, angiogenesis via VEGF-R2 upregulation
  • No FDA approval for any gastric indication in humans
  • Mechanism is plausible but untested in human GI disease
  • Crushed sciatic nerve recovery (rat)
  • Faster axonal regeneration, reduced neuropathic pain markers (paw withdrawal latency)
  • No neuropathic pain trials in humans. Central vs peripheral pain distinction critical
  • Animal neuroprotection doesn't predict human chronic neuropathic pain outcomes
  • Induced ligament injury (rat)
  • Enhanced fibroblast migration via FAK-paxillin pathway, organized ECM deposition
  • No human sports medicine or orthopedic trials published
  • Tissue repair biology is real. Patient-level chronic pain relief is speculative
More references

Related material

Comparison

BPC-157 vs Weight Loss Peptides

Many people compare BPC-157 to peptides and treatments that are specifically designed for weight management. While both fall under the broader category of peptide therapies, they …

View details →